Page 95 - BH-2-4
P. 95

Brain & Heart                                       Human DPSCs attenuated amyotrophic lateral sclerosis in mice



            indirectly. Separately, other authors declared that they   4.   Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis.
            have no known competing financial interests or personal   N Engl J Med. 2017;377(2):162-172.
            relationships that could have influenced the work reported      doi: 10.1056/NEJMra1603471
            in this paper.
                                                               5.   Batagov AO, Kurochkin IV. Exosomes secreted by human
            Author contributions                                  cells transport largely mRNA fragments that are enriched in
                                                                  the 3’-untranslated regions. Biology Direct. 2013;8:12.
            Conceptualization: Wei-Na Jin, Songling Wang, Fu-Dong      doi: 10.1186/1745-6150-8-12
               Shi
            Formal analysis: Yingying Su, Hao Wang, Jian Zhou  6.   Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral
            Methodology: Shihe Jiang, Xiuchen Guan, Meng Shi, Ying   sclerosis. Lancet. 2011;377(9769):942-955.
               Zhang, Xindi Li                                    doi: 10.1016/s0140-6736(10)61156-7
            Writing–original draft: Wei-Na Jin, Songling Wang,   7.   Bruijn LI, Houseweart MK, Kato S,  et al. Aggregation
               Fu-Dong Shi, Shihe Jiang, Xiuchen Guan             and motor neuron toxicity of an ALS-linked SOD1
            Writing–review  &  editing: Wei-Na Jin, Songling Wang,   mutant independent from wild-type  SOD1.  Science.
               Fu-Dong Shi                                        1998;281(5384):1851-1854.

            Ethics approval and consent to participate            doi: 10.1126/science.281.5384.1851
                                                               8.   Oskarsson B, Gendron TF, Staff NP. Amyotrophic
            The hDPSCs were extracted from healthy volunteers’    lateral sclerosis: An update for 2018.  Mayo Clin Proc.
            third molars, which were obtained from the Dental     2018;93(11):1617-1628.
            Clinic of the Beijing Stomatological Hospital, with ethical
            approval (Approval Number: KJ-2021-  016-C-01-CS,      doi: 10.1016/j.mayocp.2018.04.007
            Beijing, China). The written informed consent was   9.   Brooks BR, Berry JD, Ciepielewska M,  et al. Intravenous
            provided to all donors who participated in the study. All   edaravone treatment in ALS and survival: An
            experimental  procedures  were  performed  in  accordance   exploratory, retrospective, administrative claims analysis.
            with the guidelines of the Institutional Animal Care, Use   EClinicalMedicine. 2022;52:101590.
            Committee of Beijing Tiantan Hospital, and the Chinese      doi: 10.1016/j.eclinm.2022.101590
            Small Animal Protection Association Experimental   10.  Ford E, Pearlman J, Ruan T,  et al. Human pluripotent
            Protocol with approval from the IACUC under protocol   stem cells-based therapies for neurodegenerative diseases:
            number 202203004.                                     Current status and challenges. Cells. 2020;9(11):2517.
            Consent for publication                               doi: 10.3390/cells9112517

            Not applicable.                                    11.  De Gioia R, Biella F, Citterio G,  et al. Neural stem cell
                                                                  transplantation for neurodegenerative diseases. Int J Mol Sci.
            Availability of data                                  2020;21(9):3103.
            Not applicable.                                       doi: 10.3390/ijms21093103
                                                               12.  Wang D, Wang Y, Tian W, Pan J. Advances of tooth-derived
            References                                            stem cells in neural diseases treatments and nerve tissue
                                                                  regeneration. Cell Prolif. 2019;52(3):e12572.
            1.   Gitler AD, Dhillon P, Shorter J. Neurodegenerative disease:
               Models, mechanisms, and a new hope.  Dis Model Mech.      doi: 10.1111/cpr.12572
               2017;10(5):499-502.
                                                               13.  Horwitz EM, Le Blanc K, Dominici M, et al. Clarification
               doi: 10.1242/dmm.030205                            of the nomenclature for MSC: The International Society
                                                                  for Cellular Therapy position statement.  Cytotherapy.
            2.   Mehta P, Raymond J, Punjani R,  et  al. Prevalence of
               Amyotrophic Lateral Sclerosis (ALS), United States,   2005;7(5):393-395.
               2016.  Amyotroph  Lateral  Scler  Frontotemporal Degener.      doi: 10.1080/14653240500319234
               2022;23(3-4):220-225.
                                                               14.  Kim C, Lee HC, Sung JJ. Amyotrophic lateral sclerosis - Cell
               doi: 10.1080/21678421.2021.1949021                 based therapy and novel therapeutic development.  Exp
                                                                  Neurobiol. 2014;23(3):207-214.
            3.   Longinetti E, Fang F. Epidemiology of amyotrophic lateral
               sclerosis: An update of recent literature. Curr Opin Neurol.      doi: 10.5607/en.2014.23.3.207
               2019;32(5):771-776.
                                                               15.  Mortada I, Mortada R, Al Bazzal M. Dental pulp stem cells
               doi: 10.1097/wco.0000000000000730                  and neurogenesis. Adv Exp Med Biol. 2018;1083:63-75.


            Volume 2 Issue 4 (2024)                         8                                doi: 10.36922/bh.3996
   90   91   92   93   94   95   96   97   98   99   100